​

Niagen Bioscience Stock (NASDAQ:NAGE)

ForecastRevenueFinancialsChartTranscripts
Niagen Bioscience by TradingView

Previous Close

$14.07

52W Range

$2.31 - $14.49

50D Avg

$9.06

200D Avg

$6.37

Market Cap

$1.11B

Avg Vol (3M)

$843.22K

Beta

2.08

Div Yield

-

NAGE Company Profile

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

104

IPO Date

Jun 24, 2015

Website

NAGE Performance

NAGE Financial Summary

Dec 24Dec 23Dec 22
Revenue$99.60M$83.57M$72.05M
Operating Income$7.73M$-5.60M$-18.63M
Net Income$8.55M$-4.94M$-16.54M
EBITDA$9.21M$-3.89M$-16.74M
Basic EPS$0.10$-0.07$-0.24
Diluted EPS$0.11$-0.07$-0.24

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q1 25May 10, 25 | 4:30 PM
Q4 24Mar 04, 25 | 4:30 PM
Q3 24Nov 01, 24 | 4:30 PM